On November 11, Russian Federation had said that its vaccine Sputnik V is 92 per cent effective at protecting people from COVID-19 according to the first interim analysis.
Dr Slaoui said he hoped for a smooth transition and did not expect the vaccination effort to be derailed.
A Food and Drug Administration advisory committee is set to meet December 10 to discuss Pfizer Inc.'s request for an emergency use authorization for its developing Covid-19 vaccine.
The vaccine will first be made available to front-line healthcare workers and emergency responders, then to at-risk groups, like the elderly. Russian President Vladimir Putin said last week that dozens of other countries have also expressed their wish to buy Russian COVID vaccines, including EpiVacCorona, that was registered in October.
As new COVID-19 cases continue to surge, millions of Americans are ignoring federal and state warnings to stay home for Thanksgiving to prevent overwhelming already strained hospitals.
Testing shortages still plague many parts of the country with most pharmacies offering COVID-19 tests in suburban Chicago were fully booked ahead of Thanksgiving and long lines at state drive-through testing facilities. Similarly, on November 18, Pfizer had said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people. A Gallup poll from Tuesday showed that 58 percent of Americans said they would get a coronavirus vaccine and 42 percent said they wouldn't. "Most people need to be immunized before we can go back to a normal life". "The vaccines have been developed as thoroughly and as scientifically as ever", he said.
Deaths have topped 255,000 with many health experts warning deaths will rise to over 2,000 a day in the coming weeks.